[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Intravenous (IV) Therapy and Vein Access Market Size, Status and Forecast 2020-2026

May 2020 | 95 pages | ID: G27A9C1EC8BCEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Intravenous (IV) Therapy and Vein Access status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intravenous (IV) Therapy and Vein Access development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
  • B. Braun
  • Baxter International
  • Becton Dickinson
  • C. R. Bard
  • Fresenius Kabi
  • Hospira(ICU Medical)
  • Medtronic
  • Smiths Group
  • Teleflex
Market segment by Type, the product can be split into
  • Infusion pumps
  • Implantable Ports
  • Intravenous Catheters
  • Hypodermic Needles
  • Other
Market segment by Application, split into
  • Hospital
  • Clinics
  • Other
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Intravenous (IV) Therapy and Vein Access status, future forecast, growth opportunity, key market and key players.
  • To present the Intravenous (IV) Therapy and Vein Access development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Intravenous (IV) Therapy and Vein Access are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Intravenous (IV) Therapy and Vein Access Revenue
1.4 Market Analysis by Type
  1.4.1 Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Infusion pumps
  1.4.3 Implantable Ports
  1.4.4 Intravenous Catheters
  1.4.5 Hypodermic Needles
  1.4.6 Other
1.5 Market by Application
  1.5.1 Global Intravenous (IV) Therapy and Vein Access Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinics
  1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Intravenous (IV) Therapy and Vein Access Market Perspective (2015-2026)
2.2 Intravenous (IV) Therapy and Vein Access Growth Trends by Regions
  2.2.1 Intravenous (IV) Therapy and Vein Access Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Intravenous (IV) Therapy and Vein Access Historic Market Share by Regions (2015-2020)
  2.2.3 Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Intravenous (IV) Therapy and Vein Access Market Growth Strategy
  2.3.6 Primary Interviews with Key Intravenous (IV) Therapy and Vein Access Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Market Size
  3.1.1 Global Top Intravenous (IV) Therapy and Vein Access Players by Revenue (2015-2020)
  3.1.2 Global Intravenous (IV) Therapy and Vein Access Revenue Market Share by Players (2015-2020)
  3.1.3 Global Intravenous (IV) Therapy and Vein Access Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio
  3.2.1 Global Intravenous (IV) Therapy and Vein Access Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Therapy and Vein Access Revenue in 2019
3.3 Intravenous (IV) Therapy and Vein Access Key Players Head office and Area Served
3.4 Key Players Intravenous (IV) Therapy and Vein Access Product Solution and Service
3.5 Date of Enter into Intravenous (IV) Therapy and Vein Access Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Intravenous (IV) Therapy and Vein Access Historic Market Size by Type (2015-2020)
4.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Type (2021-2026)

5 INTRAVENOUS (IV) THERAPY AND VEIN ACCESS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)
5.2 Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
6.2 Intravenous (IV) Therapy and Vein Access Key Players in North America (2019-2020)
6.3 North America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
6.4 North America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
7.2 Intravenous (IV) Therapy and Vein Access Key Players in Europe (2019-2020)
7.3 Europe Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
7.4 Europe Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

8 CHINA

8.1 China Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
8.2 Intravenous (IV) Therapy and Vein Access Key Players in China (2019-2020)
8.3 China Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
8.4 China Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
9.2 Intravenous (IV) Therapy and Vein Access Key Players in Japan (2019-2020)
9.3 Japan Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
9.4 Japan Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
10.2 Intravenous (IV) Therapy and Vein Access Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
10.4 Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

11 INDIA

11.1 India Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
11.2 Intravenous (IV) Therapy and Vein Access Key Players in India (2019-2020)
11.3 India Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
11.4 India Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Intravenous (IV) Therapy and Vein Access Market Size (2015-2020)
12.2 Intravenous (IV) Therapy and Vein Access Key Players in Central & South America (2019-2020)
12.3 Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020)
12.4 Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 B. Braun
  13.1.1 B. Braun Company Details
  13.1.2 B. Braun Business Overview and Its Total Revenue
  13.1.3 B. Braun Intravenous (IV) Therapy and Vein Access Introduction
  13.1.4 B. Braun Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020))
  13.1.5 B. Braun Recent Development
13.2 Baxter International
  13.2.1 Baxter International Company Details
  13.2.2 Baxter International Business Overview and Its Total Revenue
  13.2.3 Baxter International Intravenous (IV) Therapy and Vein Access Introduction
  13.2.4 Baxter International Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.2.5 Baxter International Recent Development
13.3 Becton Dickinson
  13.3.1 Becton Dickinson Company Details
  13.3.2 Becton Dickinson Business Overview and Its Total Revenue
  13.3.3 Becton Dickinson Intravenous (IV) Therapy and Vein Access Introduction
  13.3.4 Becton Dickinson Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.3.5 Becton Dickinson Recent Development
13.4 C. R. Bard
  13.4.1 C. R. Bard Company Details
  13.4.2 C. R. Bard Business Overview and Its Total Revenue
  13.4.3 C. R. Bard Intravenous (IV) Therapy and Vein Access Introduction
  13.4.4 C. R. Bard Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.4.5 C. R. Bard Recent Development
13.5 Fresenius Kabi
  13.5.1 Fresenius Kabi Company Details
  13.5.2 Fresenius Kabi Business Overview and Its Total Revenue
  13.5.3 Fresenius Kabi Intravenous (IV) Therapy and Vein Access Introduction
  13.5.4 Fresenius Kabi Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.5.5 Fresenius Kabi Recent Development
13.6 Hospira(ICU Medical)
  13.6.1 Hospira(ICU Medical) Company Details
  13.6.2 Hospira(ICU Medical) Business Overview and Its Total Revenue
  13.6.3 Hospira(ICU Medical) Intravenous (IV) Therapy and Vein Access Introduction
  13.6.4 Hospira(ICU Medical) Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.6.5 Hospira(ICU Medical) Recent Development
13.7 Medtronic
  13.7.1 Medtronic Company Details
  13.7.2 Medtronic Business Overview and Its Total Revenue
  13.7.3 Medtronic Intravenous (IV) Therapy and Vein Access Introduction
  13.7.4 Medtronic Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.7.5 Medtronic Recent Development
13.8 Smiths Group
  13.8.1 Smiths Group Company Details
  13.8.2 Smiths Group Business Overview and Its Total Revenue
  13.8.3 Smiths Group Intravenous (IV) Therapy and Vein Access Introduction
  13.8.4 Smiths Group Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.8.5 Smiths Group Recent Development
13.9 Teleflex
  13.9.1 Teleflex Company Details
  13.9.2 Teleflex Business Overview and Its Total Revenue
  13.9.3 Teleflex Intravenous (IV) Therapy and Vein Access Introduction
  13.9.4 Teleflex Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
  13.9.5 Teleflex Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Intravenous (IV) Therapy and Vein Access Key Market Segments
Table 2. Key Players Covered: Ranking by Intravenous (IV) Therapy and Vein Access Revenue
Table 3. Ranking of Global Top Intravenous (IV) Therapy and Vein Access Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Intravenous (IV) Therapy and Vein Access Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Infusion pumps
Table 6. Key Players of Implantable Ports
Table 7. Key Players of Intravenous Catheters
Table 8. Key Players of Hypodermic Needles
Table 9. Key Players of Other
Table 10. Global Intravenous (IV) Therapy and Vein Access Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Intravenous (IV) Therapy and Vein Access Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Intravenous (IV) Therapy and Vein Access Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions (2015-2020)
Table 14. Global Intravenous (IV) Therapy and Vein Access Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Intravenous (IV) Therapy and Vein Access Market Growth Strategy
Table 20. Main Points Interviewed from Key Intravenous (IV) Therapy and Vein Access Players
Table 21. Global Intravenous (IV) Therapy and Vein Access Revenue by Players (2015-2020) (Million US$)
Table 22. Global Intravenous (IV) Therapy and Vein Access Market Share by Players (2015-2020)
Table 23. Global Top Intravenous (IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Therapy and Vein Access as of 2019)
Table 24. Global Intravenous (IV) Therapy and Vein Access by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Intravenous (IV) Therapy and Vein Access Product Solution and Service
Table 27. Date of Enter into Intravenous (IV) Therapy and Vein Access Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 30. Global Intravenous (IV) Therapy and Vein Access Market Size Share by Type (2015-2020)
Table 31. Global Intravenous (IV) Therapy and Vein Access Revenue Market Share by Type (2021-2026)
Table 32. Global Intravenous (IV) Therapy and Vein Access Market Size Share by Application (2015-2020)
Table 33. Global Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 34. Global Intravenous (IV) Therapy and Vein Access Market Size Share by Application (2021-2026)
Table 35. North America Key Players Intravenous (IV) Therapy and Vein Access Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Intravenous (IV) Therapy and Vein Access Market Share (2019-2020)
Table 37. North America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 38. North America Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 39. North America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 40. North America Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 41. Europe Key Players Intravenous (IV) Therapy and Vein Access Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Intravenous (IV) Therapy and Vein Access Market Share (2019-2020)
Table 43. Europe Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 45. Europe Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 47. China Key Players Intravenous (IV) Therapy and Vein Access Revenue (2019-2020) (Million US$)
Table 48. China Key Players Intravenous (IV) Therapy and Vein Access Market Share (2019-2020)
Table 49. China Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 50. China Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 51. China Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 52. China Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 53. Japan Key Players Intravenous (IV) Therapy and Vein Access Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Intravenous (IV) Therapy and Vein Access Market Share (2019-2020)
Table 55. Japan Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 57. Japan Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Intravenous (IV) Therapy and Vein Access Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Intravenous (IV) Therapy and Vein Access Market Share (2019-2020)
Table 61. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 63. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 65. India Key Players Intravenous (IV) Therapy and Vein Access Revenue (2019-2020) (Million US$)
Table 66. India Key Players Intravenous (IV) Therapy and Vein Access Market Share (2019-2020)
Table 67. India Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 68. India Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 69. India Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 70. India Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Intravenous (IV) Therapy and Vein Access Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Intravenous (IV) Therapy and Vein Access Market Share (2019-2020)
Table 73. Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Intravenous (IV) Therapy and Vein Access Market Share by Type (2015-2020)
Table 75. Central & South America Intravenous (IV) Therapy and Vein Access Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Intravenous (IV) Therapy and Vein Access Market Share by Application (2015-2020)
Table 77. B. Braun Company Details
Table 78. B. Braun Business Overview
Table 79. B. Braun Product
Table 80. B. Braun Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 81. B. Braun Recent Development
Table 82. Baxter International Company Details
Table 83. Baxter International Business Overview
Table 84. Baxter International Product
Table 85. Baxter International Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 86. Baxter International Recent Development
Table 87. Becton Dickinson Company Details
Table 88. Becton Dickinson Business Overview
Table 89. Becton Dickinson Product
Table 90. Becton Dickinson Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 91. Becton Dickinson Recent Development
Table 92. C. R. Bard Company Details
Table 93. C. R. Bard Business Overview
Table 94. C. R. Bard Product
Table 95. C. R. Bard Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 96. C. R. Bard Recent Development
Table 97. Fresenius Kabi Company Details
Table 98. Fresenius Kabi Business Overview
Table 99. Fresenius Kabi Product
Table 100. Fresenius Kabi Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 101. Fresenius Kabi Recent Development
Table 102. Hospira(ICU Medical) Company Details
Table 103. Hospira(ICU Medical) Business Overview
Table 104. Hospira(ICU Medical) Product
Table 105. Hospira(ICU Medical) Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 106. Hospira(ICU Medical) Recent Development
Table 107. Medtronic Company Details
Table 108. Medtronic Business Overview
Table 109. Medtronic Product
Table 110. Medtronic Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 111. Medtronic Recent Development
Table 112. Smiths Group Business Overview
Table 113. Smiths Group Product
Table 114. Smiths Group Company Details
Table 115. Smiths Group Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 116. Smiths Group Recent Development
Table 117. Teleflex Company Details
Table 118. Teleflex Business Overview
Table 119. Teleflex Product
Table 120. Teleflex Revenue in Intravenous (IV) Therapy and Vein Access Business (2015-2020) (Million US$)
Table 121. Teleflex Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Intravenous (IV) Therapy and Vein Access Market Share by Type: 2020 VS 2026
Figure 2. Infusion pumps Features
Figure 3. Implantable Ports Features
Figure 4. Intravenous Catheters Features
Figure 5. Hypodermic Needles Features
Figure 6. Other Features
Figure 7. Global Intravenous (IV) Therapy and Vein Access Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Intravenous (IV) Therapy and Vein Access Report Years Considered
Figure 12. Global Intravenous (IV) Therapy and Vein Access Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions: 2020 VS 2026
Figure 14. Global Intravenous (IV) Therapy and Vein Access Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Intravenous (IV) Therapy and Vein Access Market Share by Players in 2019
Figure 17. Global Top Intravenous (IV) Therapy and Vein Access Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Therapy and Vein Access as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Intravenous (IV) Therapy and Vein Access Revenue in 2019
Figure 19. North America Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Intravenous (IV) Therapy and Vein Access Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. B. Braun Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 28. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Baxter International Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 30. Becton Dickinson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Becton Dickinson Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 32. C. R. Bard Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. C. R. Bard Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 34. Fresenius Kabi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Fresenius Kabi Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 36. Hospira(ICU Medical) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Hospira(ICU Medical) Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 38. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Medtronic Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 40. Smiths Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Smiths Group Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 42. Teleflex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Teleflex Revenue Growth Rate in Intravenous (IV) Therapy and Vein Access Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed


More Publications